Gelion (LSE:GELN) has signed an exclusive commercial licence agreement through its 100%‑owned subsidiary Gelion Technologies Pty with Max‑Planck‑Innovation, securing long‑term, global rights to nano‑encapsulated sulfur cathode and nano‑confined anode intellectual property.
The licence converts an exclusive option granted under a March 2025 collaboration agreement into a binding commercial deal and expressly covers Background IP and the option to extend rights to Foreground IP arising from the April 2025 cooperation with the Max Planck Institute of Colloids and Interfaces.
"The MPG technology has more than delivered on our expectations, and it is now appropriate to conclude a commercial licence for Gelion to extend our development and materials testing toward the start of commercial collaboration activities," John Wood, Gelion CEO, said.
Under the agreement Gelion will make staged cash payments tied to technical milestones and pay royalties on net sales of Nano‑Encapsulated Sulfur Cathode Active Materials, with both the payments and royalties described as being on fair market commercial terms.
Max‑Planck‑Innovation, the Max‑Planck Society’s technology transfer arm, contributes the IP and Gelion gains the right to integrate the NES™ materials into its proprietary battery architectures after research that the company says improved energy density, power capability, operating temperature range and cycle life.
Gelion said the licence materially strengthens its IP position, reduces commercialisation risk and enables acceleration of integration toward commercial deployment of its next‑generation sulfur battery technologies.
